UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects

Clinical pharmacokinetics, 2004, Vol.43 (7), p.479-486

2004

Volltextzugriff (PDF)

Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

The Lancet (British edition), 2005-08, Vol.366 (9485), p.563-571

2005

Volltextzugriff (PDF)

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

Thorax, 2007-12, Vol.62 (12), p.1081-1087

2007

Volltextzugriff (PDF)

Pharmacology, clinical efficacy, and tolerability of phosphodiesterase-4 inhibitors: impact of human pharmacokinetics

Handbook of experimental pharmacology, 2011 (204), p.85

2011

Volltextzugriff (PDF)

Absence of Pharmacokinetic Interaction Between Roflumilast and Digoxin in Healthy Adults

Journal of clinical pharmacology, 2012-02, Vol.52 (2), p.251-257

2012

Volltextzugriff (PDF)

Dose-Proportional Intraindividual Single- and Repeated-Dose Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor

Journal of clinical pharmacology, 2007-01, Vol.47 (1), p.26-36

2007

Volltextzugriff (PDF)

Use of Recombinant Human Parathyroid Hormone(1–84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain – the PROPOSE Study

Clinical drug investigation, 2011, Vol.31 (2), p.1

2011

Volltextzugriff (PDF)

Efficacy and safety of ciclesonide in the treatment of 24,037 asthmatic patients in routine medical care

Respiratory medicine, 2011-02, Vol.105 (2), p.186-194

2011

Volltextzugriff (PDF)

Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects

European journal of clinical pharmacology, 2005-05, Vol.61 (3), p.203-208

2005

Volltextzugriff (PDF)

CHRONOPHARMACOLOGY OF ROFLUMILAST: A COMPARATIVE PHARMACOKINETIC STUDY OF MORNING VERSUS EVENING ADMINISTRATION IN HEALTHY ADULTS

Chronobiology international, 2010-12, Vol.27 (9-10), p.1843-1853

2010

Volltextzugriff (PDF)

Use of Recombinant Human Parathyroid Hormone(1–84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain — the PROPOSE Study

Clinical drug investigation, 2011-02, Vol.31 (2), p.87-99

2011

Volltextzugriff (PDF)

Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa)

German medical science, 2015, Vol.13, p.Doc02-Doc02

2015

Volltextzugriff (PDF)

Investigation of a Potential Food Effect on the Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor, in Healthy Subjects

Journal of clinical pharmacology, 2006-10, Vol.46 (10), p.1146-1153

2006

Volltextzugriff (PDF)

Comparison of the efficacy and safety of ciclesonide 160 μg once daily vs. budesonide 400 μg once daily in children with asthma

Pediatric allergy and immunology, 2007-08, Vol.18 (5), p.391-400

2007

Volltextzugriff (PDF)

Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber plus™ spacer for inhalation

Clinical pharmacokinetics, 2006-01, Vol.45 (7), p.729-736

2006

Volltextzugriff (PDF)

The Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast Lacks Relevant Pharmacokinetic Interactions With Inhaled Budesonide

Journal of clinical pharmacology, 2007-08, Vol.47 (8), p.1005-1013

2007

Volltextzugriff (PDF)

Results of a survey on applied quality standards in non-interventional studies among the members of the German Association of Research-based Pharmaceutical Companies

German medical science, 2010-10, Vol.8, p.Doc29-Doc29

2010

Volltextzugriff (PDF)

Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers

Journal of aerosol medicine, 2006-06, Vol.19 (2), p.117

2006

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics of Roflumilast in Children and Adolescents

Journal of clinical pharmacology, 2008-08, Vol.48 (8), p.978-985

2008

Volltextzugriff (PDF)

Cure of Helicobacter pylori infection and healing of duodenal ulcer : Comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy

The American journal of gastroenterology, 1998-10, Vol.93 (10), p.1919-1924

1998

Volltextzugriff (PDF)

CHRONOPHARMACOLOGY OF ROFLUMILAST: A COMPARATIVE PHARMACOKINETIC STUDY OF MORNING VERSUS EVENING ADMINISTRATION IN HEALTHY ADULTS

Chronobiology international, 2010-12, Vol.27 (9-10), p.1843-1853

2010

Volltextzugriff (PDF)

Effects of multiple-dose esomeprazole and pantoprazole on diazepam pharmacokinetic profile and pharmacodynamic effects on cognitive and psychomotor function in healthy volunteers

Arzneimittel-Forschung, 2010-01, Vol.60 (8), p.483

2010

Volltextzugriff (PDF)

Pharmacokinetics of [[sup.14]C]ciclesonide after oral and intravenous administration to healthy subjects

Clinical pharmacokinetics, 2004-07, Vol.43 (7), p.479

2004

Volltextzugriff (PDF)

Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma

Pediatric allergy and immunology, 2007-08, Vol.18 (5), p.391

2007

Volltextzugriff (PDF)

Quality assurance measures in non-interventional studies: Results of a survey among the members of the Association of Research-Based Pharmaceutical Companies

German medical science, 2008-11, Vol.6, p.Doc12

2008

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(128)
Buchkapitel
(1)

Sprache

Englisch
(128)
Japanisch
(5)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(32)
Humans
(27)
Biological And Medical Sciences
(21)
Male
(20)
Medical Sciences
(20)
Female
(18)
Adult
(16)
Middle Aged
(12)
Pharmacology & Pharmacy
(12)
Pharmacology. Drug Treatments
(11)
Cross-Over Studies
(9)
Aged
(8)
Area Under Curve
(8)
Pregnenediones - Administration & Dosage
(7)
Roflumilast
(7)
Administration, Inhalation
(6)
Aged, 80 And Over
(6)
Aminopyridines - Administration & Dosage
(6)
Aminopyridines - Pharmacokinetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects

Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

Pharmacology, clinical efficacy, and tolerability of phosphodiesterase-4 inhibitors: impact of human pharmacokinetics

Absence of Pharmacokinetic Interaction Between Roflumilast and Digoxin in Healthy Adults

Dose-Proportional Intraindividual Single- and Repeated-Dose Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor

Use of Recombinant Human Parathyroid Hormone(1–84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain – the PROPOSE Study

Efficacy and safety of ciclesonide in the treatment of 24,037 asthmatic patients in routine medical care

Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects

CHRONOPHARMACOLOGY OF ROFLUMILAST: A COMPARATIVE PHARMACOKINETIC STUDY OF MORNING VERSUS EVENING ADMINISTRATION IN HEALTHY ADULTS

Use of Recombinant Human Parathyroid Hormone(1–84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain — the PROPOSE Study

Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa)

Investigation of a Potential Food Effect on the Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor, in Healthy Subjects

Comparison of the efficacy and safety of ciclesonide 160 μg once daily vs. budesonide 400 μg once daily in children with asthma

Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber plus™ spacer for inhalation

The Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast Lacks Relevant Pharmacokinetic Interactions With Inhaled Budesonide

Results of a survey on applied quality standards in non-interventional studies among the members of the German Association of Research-based Pharmaceutical Companies

Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers

Single-Dose Pharmacokinetics of Roflumilast in Children and Adolescents

Cure of Helicobacter pylori infection and healing of duodenal ulcer : Comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy

CHRONOPHARMACOLOGY OF ROFLUMILAST: A COMPARATIVE PHARMACOKINETIC STUDY OF MORNING VERSUS EVENING ADMINISTRATION IN HEALTHY ADULTS

Effects of multiple-dose esomeprazole and pantoprazole on diazepam pharmacokinetic profile and pharmacodynamic effects on cognitive and psychomotor function in healthy volunteers

Pharmacokinetics of [[sup.14]C]ciclesonide after oral and intravenous administration to healthy subjects

Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma

Quality assurance measures in non-interventional studies: Results of a survey among the members of the Association of Research-Based Pharmaceutical Companies

Suchergebnisse filtern